OPTI — Optimi Health Share News
0.000.00%
Last trade - 00:00- CA$26.05m
- CA$18.12m
- CA$0.43m
Brief: Optimi Health Corp - Trial Initiation Planned For H1 2027, Dosing To Complete By End Of 2027
Brief: Optimi Health Offers 2.4 MLn Common Shares At A Public Offering Price Of US$6.25 Per Share
Brief: Optimi Health Corp Now Sees IPO Of 2.4 Million Common Shares
Trump's psychedelic drug order boosts investor interest with promise of faster reviews
Explainer: What to know about psychedelic therapies cited by Trump
Brief: Optimi Health Corp - Have Applied To List Common Shares On Nasdaq Capital Market Under Trading Symbol “Opth”
Brief: Optimi Health, ATMA Sign Letter of Intent To Advance Phase II Clinical Trial Group and Individual Administration Protocol For Major Depressive Disorder
Brief: Optimi Announces Closing Of First Tranche Of Non-Brokered Private Placement
Brief: Sunshine Earth Labs Sign Supply Agreement With Optimi Health Corp
Brief: Optimi Health Welcomes Preston A. Chase As New Chief Science Officer
Brief: Optimi Health Announces Third And Final Tranche Of CAD $1,000,000 Secured For Debt Financing
Brief: Optimi Health Announces CAD$1.2 Million GMP Psilocybin Supply Agreement For Clinical Research And Development
Brief: Optimi Health Announces Re-Appointments To Board Of Directors
Brief: Optimi Health Announces Canadian Retail And E-Commerce Distribution Agreements For Functional Mushroom Supplements
Brief: Optimi Health Initiates Agreement With Sabi Mind For Therapeutic Supplies Of Psilocybin, MDMA
Brief: Optimi Health Finalizes Partnership And Psilocybin Supply Agreement With Atma Journey Centers
Brief: Optimi Health Approved to Supply Psilocybin Under Health Canada's Special Access Program
Brief: Optimi Health Initiates Pathway To Nasdaq Listing
Brief: Numinus Wellness And Optimi Health Submit All-Natural Psilocybin Extract To Health Canada For Pre-Clinical Trial Application